Index by author

November 01, 2011; Volume 78,Issue 11 suppl 2

Progressive Multifocal Leukoencephalopathy in the Biologic ERA: Implications for Practice

  1. Bennett, Charles L.

    1. Pharmacovigilance and PML in the oncology setting
      Charles L. Bennett, MD, PhD, MPP
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S13-S17; DOI: https://doi.org/10.3949/ccjm.78.s2.04

  2. Berger, Joseph R.

    1. The clinical features of PML
      Joseph R. Berger, MD
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S8-S12; DOI: https://doi.org/10.3949/ccjm.78.s2.03

  3. Calabrese, Leonard

    1. Introduction
      Leonard Calabrese, DO
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S2; DOI: https://doi.org/10.3949/ccjm.78.s2.01
    2. A rational approach to PML for the clinician
      Leonard Calabrese, DO
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S38-S41; DOI: https://doi.org/10.3949/ccjm.78.s2.09

  4. Fox, Robert

    1. Advances in the management of PML: Focus on natalizumab
      Robert Fox, MD
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S33-S37; DOI: https://doi.org/10.3949/ccjm.78.s2.08

  5. Major, Eugene O.

    1. History and current concepts in the pathogenesis of PML
      Eugene O. Major, PhD
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S3-S7; DOI: https://doi.org/10.3949/ccjm.78.s2.02

  6. Molloy, Eamonn S.

    1. PML and rheumatology: The contribution of disease and drugs
      Eamonn S. Molloy, MD, MS, MRCPI
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S28-S32; DOI: https://doi.org/10.3949/ccjm.78.s2.07

  7. Rudick, Richard A.

    1. Multiple sclerosis, natalizumab, and PML: Helping patients decide
      Richard A. Rudick, MD
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.78.s2.05

  8. Simpson, David M.

    1. HIV-associated PML: Changing epidemiology and clinical approach
      David M. Simpson, MD, FRCP, FAAN
      Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S24-S27; DOI: https://doi.org/10.3949/ccjm.78.s2.06
Back to top

In this issue